Blog

Genetics Adviser

May 22, 2025, 09:24

Proud to Support Our Partners who are Advancing the Future of Precision Medicine – Genetics Adviser

Genetics Adviser shared a post on LinkedIn:

“Proud to support our partners who are advancing the future of precision medicine!

Join us at ESHG2025 in Milan as thought leaders from Murdoch Children’s Research Institute (MCRI)’s and Victorian Clinical Genetics Services (VCGS) share their insights on genomic newborn screening.

Don’t miss these important sessions on Monday, May 26 — exploring lifelong data use, program learnings, and clinical outcomes in prospective cohorts.”

Genetics Adviser announced key genomic newborn screening sessions at ESHG2025 featuring experts from MCRI and VCGS. The presentations will address data use, program insights, and outcomes from prospective studies.

Proud to Support Our Partners who are Advancing the Future of Precision Medicine - Genetics Adviser

More posts featuring Genetics Adviser.

cancer ESHG2025 fight against cancer Genetics Adviser Global fight against cancer MCRI Murdoch Children's Research Institute OncoDaily Oncology Precision Medicine VCGS Victorian Clinical Genetics Services

Uhm Jung-hwa: Korea’s Iconic ‘Madonna’ and Her Triumphant Battle Against Thyroid Cancer

Vincent Rajkumar: A Historic Day for High Risk Smoldering Myeloma

Dr. Anastasia Constantinidou Nominated for Madame Figaro Woman of the Year 2025

Lisa A. Lacasse Welcomed Shane Jacobson as the New CEO of the ACS and the ACS CAN

ASCO and Community Oncology Alliance Have Released the Updated Oncology Medical Home Standards